Ludwig Hantson Alexion Pharmaceuticals, Inc. (ALXN) insider trading activity

Ludwig Hantson is CEO of ALEXION PHARMACEUTICALS, INC.. Currently has a direct ownership of 9,098 shares of ALXN, which is worth approximately $1.66 Million. The most recent transaction as insider was on Jul 21, 2021, when has been sold 580,809 shares (Common Stock, par value $.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.1K

0% 3M change

0% 12M change

Total Value Held $1.66 Million

LUDWIG HANTSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 21 2021	SELL Sale (or disposition) back to the issuer	-	580,809 Reduced 98.46%	9,098 Common Stock, par valu...
Jul 14 2021	BUY Grant, award, or other acquisition	-	240,741 Added 28.98%	589,907 Common Stock, par valu...
Mar 29 2021	SELL Payment of exercise price or tax liability	$359,198 $154.03 p/Share	2,332 Reduced 0.66%	349,166 Common Stock, par valu...
Feb 28 2021	BUY Grant, award, or other acquisition	-	83,725 Added 19.24%	351,498 Common Stock, par valu...
Dec 16 2020	SELL Payment of exercise price or tax liability	$13,520,113 $157.96 p/Share	85,592 Reduced 24.22%	267,773 Common Stock, par valu...
Dec 16 2020	BUY Grant, award, or other acquisition	-	162,707 Added 31.53%	353,365 Common Stock, par valu...

Also insider at

HOLX

HOLOGIC INC Healthcare

Director

Ludwig Hantson

CEO

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXN shares.

Notify only if

Value

Insider Trading

Get notified when an Alexion Pharmaceuticals, Inc. insider buys or sells ALXN shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALEXION PHARMACEUTICALS, INC.

Track Activities on ALXN

Account